NCT06932679 Perception of Affordances and Obstacle Crossing in People With Parkinson's Disease and Healthy Adults
| NCT ID | NCT06932679 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Haifa |
| Condition | Parkinson's Disease (PD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 180 participants |
| Start Date | 2025-04-24 |
| Primary Completion | 2028-04-24 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 180 participants in total. It began in 2025-04-24 with a primary completion date of 2028-04-24.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to explore how young adults, older adults and people with Parkinson's disease (PwP), perceive their abilty to cross obstacles while walking, and how this perception is related to their actual performance of obstacle crossing and disease-related motor and cognitive impairments. The study will explore this percepeption and the actual performance in different walking environments(floor, synthetic grass turf). Understanding how people perceive obstacles may help improve rehabilitation methods and reduce the risk of falls. The study will take place at the Motor Performance Laboratory, University of Haifa, and will include walking tasks, eye-tracking measurements, and motor and cognitive assessments.
Eligibility Criteria
Inclusion Criteria: * Participants aged 20 to 80 years. * Ability to walk independently outdoors without assistive devices. * For Parkinson's Disease (PD) group: Diagnosis of PD confirmed by medical records. * For healthy control groups: No neurological or orthopedic conditions affecting gait. Exclusion Criteria: * Feezing of gait (for PD group only), based on a score greater than 0 on the Freezing of Gait Questionnaire. * Severe visual impairment that cannot be corrected with glasses or lenses. * Cognitive impairment, defined as a score below 18 on the telephone-based Mini-Mental State Examination (MMSE). * Any orthopedic condition, pain, or other medical condition that may affect walking, based on self-report.
Contact & Investigator
Galit Yogev Seligmann, PhD
PRINCIPAL INVESTIGATOR
University of Haifa
Frequently Asked Questions
Who can join the NCT06932679 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 80 Years, studying Parkinson's Disease (PD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06932679 currently recruiting?
Yes, NCT06932679 is actively recruiting participants. Contact the research team at galit.yogev@gmail.com for enrollment information.
Where is the NCT06932679 trial being conducted?
This trial is being conducted at Haifa, Israel.
Who is sponsoring the NCT06932679 clinical trial?
NCT06932679 is sponsored by University of Haifa. The principal investigator is Galit Yogev Seligmann, PhD at University of Haifa. The trial plans to enroll 180 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.